Note: Yurogen Biosystems's revenues are gauged from an analysis of company filings.
Yurogen Biosystems's Income Statement (based on Industry Averages)
Yurogen Biosystems P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Yurogen Biosystems is developing and marketing.
Yurogen Biosystems doesn't have any recent trademark applications, indicating Yurogen Biosystems is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
YUROGEN Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
07/20/2015
See all trademarks and details in the Full Report.
Market Share of Yurogen Biosystems's Largest Competitors
A competitive analysis shows these companies are in the same general field as Yurogen Biosystems, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Yurogen Biosystems.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Yurogen Biosystems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.